These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36644116)

  • 21. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 22. CHILDREN AND ADOLESCENTS WITH GENDER DYSPHORIA IN ISRAEL: INCREASING REFERRAL AND FERTILITY PRESERVATION RATES.
    Segev-Becker A; Israeli G; Elkon-Tamir E; Perl L; Sekler O; Amir H; Interator H; Dayan SC; Chorna E; Weintrob N; Oren A
    Endocr Pract; 2020 Apr; 26(4):423-428. PubMed ID: 32045294
    [No Abstract]   [Full Text] [Related]  

  • 23. The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.
    Spanos C; Grace JA; Leemaqz SY; Brownhill A; Cundill P; Locke P; Wong P; Zajac JD; Cheung AS
    J Sex Med; 2021 Jan; 18(1):201-208. PubMed ID: 33249011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrinological Follow-Up Characteristics of People Diagnosed with Gender Dysphoria in Turkey.
    Durcan E; Sulu C; Şahin S; Gioventikli A; Dedeoğlu SE; Azamet İ; Taze SS; Özkaya HM; Turan Ş; Kadıoğlu P
    Transgend Health; 2022 Jun; 7(3):250-260. PubMed ID: 36643062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
    Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
    J Sex Med; 2022 Jul; 19(7):1173-1184. PubMed ID: 35418328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.
    Tordoff DM; Wanta JW; Collin A; Stepney C; Inwards-Breland DJ; Ahrens K
    JAMA Netw Open; 2022 Feb; 5(2):e220978. PubMed ID: 35212746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Zurich Specialist Clinic for Adolescent with Gender Dysphoria - Preliminary Follow-up Results].
    Pauli D; Günthard M; Schenker T; Flütsch N; Ball J; Häberling I; Berger G
    Prax Kinderpsychol Kinderpsychiatr; 2020 Sep; 69(6):570-589. PubMed ID: 32988309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fertility preservation for transgender adolescents and young adults: a systematic review.
    Baram S; Myers SA; Yee S; Librach CL
    Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identity Integration in Adolescents With Features of Gender Dysphoria Compared to Adolescents in General Population.
    Karvonen M; Goth K; Eloranta SJ; Kaltiala R
    Front Psychiatry; 2022; 13():848282. PubMed ID: 35757222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Mental Health and Psychosocial Functioning of Transgender Adolescents Seeking Gender-Affirming Hormone Therapy.
    Kuper LE; Mathews S; Lau M
    J Dev Behav Pediatr; 2019; 40(8):589-596. PubMed ID: 31166250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nature of co-morbid psychopathology in adolescents with gender dysphoria.
    Karvonen M; Karukivi M; Kronström K; Kaltiala R
    Psychiatry Res; 2022 Nov; 317():114896. PubMed ID: 37732850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Quality of Life of Transgender and Gender-Diverse Children and Adolescents in Melbourne, Australia, 2017-2020.
    Engel L; Majmudar I; Mihalopoulos C; Tollit MA; Pang KC
    JAMA Netw Open; 2023 Feb; 6(2):e2254292. PubMed ID: 36729456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
    Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
    Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.